Related Experiment Video
Updated: Apr 22, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
[Trans-intestinal cholesterol excretion (TICE): a new route for cholesterol excretion]
Claire Blanchard1, François Moreau1, Bertrand Cariou1
1IRS-UN, institut du thorax, unité Inserm UMR 1087/CNRS UMR 6291, 8, quai Moncousu, 44007 Nantes Cedex 1, France.
Abstract:
The small intestine plays a crucial role in dietary and biliary cholesterol absorption, as well as its lymphatic secretion as chylomicrons (lipoprotein exogenous way). Recently, a new metabolic pathway called TICE (trans-intestinal excretion of cholesterol) that plays a central role in cholesterol metabolism has emerged. TICE is an inducible way, complementary to the hepatobiliary pathway, allowing the elimination of the plasma cholesterol directly into the intestine lumen through the enterocytes. This pathway is poorly characterized but several molecular actors of TICE have been recently identified. Although it is a matter of debate, two independent studies suggest that TICE is involved in the anti-atherogenic reverse cholesterol transport pathway. Thus, TICE is an innovative drug target to reduce -cardiovascular diseases.
Related Concept Videos
Drug Excretion: Miscellaneous Routes
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Excretion: Influencing Factors
Drug Elimination: Non-Renal Routes
Cholesterol: Significance and Regulation
Considering cholesterol and...

